IgA nephropathy trials in Sri Lanka

2 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  Study of WAL0921 in Patients With Glomerular Kidney Diseases

  Where

  Colombo, Jaffna, Kandy, Kurunegala, Werahera

  Age

  18 years to 75 years

  People

  96 worldwide

  Run by

  Walden Biosciences

  See details and how to joinNCT06466135
• Phase 2/3Enrolling by invitation
  Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN)

  Where

  Colombo, Kandy, Kurunegala, Nugegoda

  Age

  18 years and over

  People

  600 worldwide

  Run by

  Otsuka Pharmaceutical Development & Commercialization, Inc.

  See details and how to joinNCT05248659